These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2760472)

  • 1. Separation of active and inactive forms of the third component of human complement, C3, by fast protein liquid chromatography (FPLC).
    Sánchez-Corral P; Antón LC; Alcolea JM; Marqués G; Sánchez A; Vivanco F
    J Immunol Methods; 1989 Aug; 122(1):105-13. PubMed ID: 2760472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The separation of functionally distinct forms of the third component of human complement (C3).
    Parkes C; DiScipio RG; Kerr MA; Prohaska R
    Biochem J; 1981 Mar; 193(3):963-70. PubMed ID: 6458280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorimetric assay for native C3. The hemolytically active form of the third component of human complement.
    Pangburn MK
    J Immunol Methods; 1987 Aug; 102(1):7-14. PubMed ID: 3624878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rapid FPLC method for purification of the third component of human and guinea pig complement.
    Basta M; Hammer CH
    J Immunol Methods; 1991 Aug; 142(1):39-44. PubMed ID: 1919020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid isolation and characterization of native mouse complement components C3 and C5.
    Van den Berg CW; Van Dijk H; Capel PJ
    J Immunol Methods; 1989 Aug; 122(1):73-8. PubMed ID: 2760478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of the third component of bovine complement.
    Menger M; Aston WP
    Vet Immunol Immunopathol; 1985 Dec; 10(4):317-31. PubMed ID: 3832572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation of different forms of the fourth component of human complement by fast protein liquid chromatography.
    Hessing M; Paardekooper J; Hack CE
    J Immunol Methods; 1993 Jan; 157(1-2):39-48. PubMed ID: 8423373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    Pangburn MK; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Sep; 154(3):856-67. PubMed ID: 6912277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of complement fragments C3b and C3a from purified rat complement component C3 by activated cobra venom factor.
    Usami M; Ohno Y
    J Pharmacol Toxicol Methods; 2005; 52(2):260-3. PubMed ID: 16125624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Component C3 of hagfish complement has a unique structure: identification of native C3 and its degradation products.
    Fujii T; Nakamura T; Tomonaga S
    Mol Immunol; 1995 Jun; 32(9):633-42. PubMed ID: 7643855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavoxobin, a serine protease from Trimeresurus flavoviridis (habu snake) venom, independently cleaves Arg726-Ser727 of human C3 and acts as a novel, heterologous C3 convertase.
    Yamamoto C; Tsuru D; Oda-Ueda N; Ohno M; Hattori S; Kim ST
    Immunology; 2002 Sep; 107(1):111-7. PubMed ID: 12225369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3.
    Pangburn MK; Müller-Eberhard HJ
    Ann N Y Acad Sci; 1983; 421():291-8. PubMed ID: 6586103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression, purification, and characterization of third component of complement.
    Lao Z; Wang Y; Mavroidis M; Kostavasili I; Lambris JD
    J Immunol Methods; 1994 Nov; 176(1):127-39. PubMed ID: 7963591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Third component of rat complement. Purification from plasma and radioimmunoassay in culture media from cell lines.
    Guiguet M; Dethieux MC; Exilie-Frigère MF; Bidan Y; Lautissier JL; Mack G
    J Immunol Methods; 1987 Feb; 96(2):157-64. PubMed ID: 3805737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation of C3 cleavage in the alternative complement pathway.
    Fearon DT; Austen KF
    J Immunol; 1975 Nov; 115(5):1357-61. PubMed ID: 809512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of the fifth component of the bovine complement system.
    Aston WP; Mhatre A; Macrae J
    Vet Immunol Immunopathol; 1990 Apr; 24(4):301-12. PubMed ID: 2140216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Third component of complement (C3): structural properties in relation to functions.
    Bokisch VA; Dierich MP; Mūller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1975 Jun; 72(6):1989-93. PubMed ID: 1056006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of complement component C3 to antibody-antigen aggregates after activation of the alternative pathway in human serum.
    Gadd KJ; Reid KB
    Biochem J; 1981 May; 195(2):471-80. PubMed ID: 7316962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the Role of C3(H
    Fromell K; Adler A; Åman A; Manivel VA; Huang S; Dührkop C; Sandholm K; Ekdahl KN; Nilsson B
    Front Immunol; 2020; 11():530. PubMed ID: 32296436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.